Ute Priglinger

742 total citations
17 papers, 556 citations indexed

About

Ute Priglinger is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Cancer Research. According to data from OpenAlex, Ute Priglinger has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Ute Priglinger's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Ute Priglinger is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Ute Priglinger collaborates with scholars based in Austria. Ute Priglinger's co-authors include Georg Delle Karth, Alexander Geppert, Thomas Neunteufl, Gottfried Heinz, Peter Siostrzonek, Bernd R. Binder, Margarethe Geiger, Kurt Huber, Markus Haumer and Michael E. Gschwandtner and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of the American College of Cardiology.

In The Last Decade

Ute Priglinger

17 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Priglinger Austria 10 276 105 96 88 67 17 556
Selim İşbir Türkiye 13 128 0.5× 162 1.5× 30 0.3× 31 0.4× 35 0.5× 60 438
H. Lackner United States 17 277 1.0× 299 2.8× 125 1.3× 240 2.7× 53 0.8× 29 873
Giovanni Melandri Italy 15 461 1.7× 206 2.0× 127 1.3× 49 0.6× 19 0.3× 51 749
Mojca Božič Mijovski Slovenia 16 328 1.2× 189 1.8× 206 2.1× 155 1.8× 16 0.2× 70 713
H. Köstering Germany 11 131 0.5× 149 1.4× 94 1.0× 131 1.5× 14 0.2× 34 417
Yílmaz Nişancí Türkiye 16 653 2.4× 313 3.0× 141 1.5× 37 0.4× 30 0.4× 40 870
H. G. Lasch Germany 14 99 0.4× 131 1.2× 56 0.6× 197 2.2× 44 0.7× 67 701
J. Fareed United States 14 207 0.8× 249 2.4× 280 2.9× 210 2.4× 37 0.6× 44 605
Erik Stoffersen Denmark 13 140 0.5× 109 1.0× 103 1.1× 139 1.6× 17 0.3× 24 549
Aria P. Yazdanbakhsh Netherlands 8 619 2.2× 265 2.5× 67 0.7× 21 0.2× 24 0.4× 11 810

Countries citing papers authored by Ute Priglinger

Since Specialization
Citations

This map shows the geographic impact of Ute Priglinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Priglinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Priglinger more than expected).

Fields of papers citing papers by Ute Priglinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Priglinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Priglinger. The network helps show where Ute Priglinger may publish in the future.

Co-authorship network of co-authors of Ute Priglinger

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Priglinger. A scholar is included among the top collaborators of Ute Priglinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Priglinger. Ute Priglinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Brunner, Patrick M., et al.. (2011). Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells. Blood. 117(15). 4154–4161. 25 indexed citations
3.
Brunner, Patrick M., et al.. (2006). ID: 348 The density enhanced phosphatase 1 (DEP-1) down-modulates urokinase receptor (uPAR) surface expression in confluent endothelial cells. Journal of Thrombosis and Haemostasis. 4(s1). 237–237. 2 indexed citations
4.
Priglinger, Ute, Georg Delle Karth, Alexander Geppert, et al.. (2003). Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?*. Critical Care Medicine. 31(5). 1405–1409. 109 indexed citations
5.
Kopp, Christoph, Sabine Steiner, Ute Priglinger, et al.. (2003). Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting. Blood Coagulation & Fibrinolysis. 14(4). 379–386. 5 indexed citations
6.
Priglinger, Ute, Johannes Drach, Roman Ullrich, et al.. (2002). Idiopathic Eosinophilic Endomyocarditis in the Absence of Peripheral Eosinophilia. Leukemia & lymphoma. 43(1). 215–218. 10 indexed citations
7.
Koreny, Maria, Georg Delle Karth, Alexander Geppert, et al.. (2002). Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. The American Journal of Medicine. 112(2). 115–119. 90 indexed citations
8.
Stiebellehner, Leopold, et al.. (2002). [Manual compression versus mechanical compression device (FemoStop) after diagnostic coronary angiography with/without intervention].. PubMed. 114(19-20). 847–52. 9 indexed citations
9.
Priglinger, Ute, Georg Delle Karth, Alexander Geppert, et al.. (2002). Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?. Critical Care. 6(Suppl 1). P126–P126. 1 indexed citations
10.
Karth, Georg Delle, Alexander Geppert, Thomas Neunteufl, et al.. (2001). Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Critical Care Medicine. 29(6). 1149–1153. 113 indexed citations
11.
Neunteufl, Thomas, Ute Priglinger, Sandra Heher, et al.. (2000). Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. Journal of the American College of Cardiology. 35(2). 277–283. 98 indexed citations
12.
Priglinger, Ute & Kurt Huber. (2000). Thrombolytic Therapy in Acute Myocardial Infarction. Drugs & Aging. 16(4). 301–312. 3 indexed citations
13.
Geiger, Margarethe, Pavel Uhrín, Peter Hufnagl, et al.. (1996). Protein C inhibitor (PCI). Immunopharmacology. 32(1-3). 53–56. 23 indexed citations
14.
Priglinger, Ute, et al.. (1994). Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598). The role of glycosaminoglycans present on the luminal cell surface.. Journal of Biological Chemistry. 269(20). 14705–14710. 31 indexed citations
15.
Priglinger, Ute, et al.. (1994). Characterization of protein c inhibitor (PCI)-binding glycosaminoglycans (GAGs) of epithelial kidney tumor cells (TCL-598). Fibrinolysis and Proteolysis. 8. 63–63. 1 indexed citations
16.
Geiger, Margarethe, Ute Priglinger, John H. Griffin, & Bernd R. Binder. (1991). Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase. Journal of Biological Chemistry. 266(18). 11851–11857. 34 indexed citations
17.
Geiger, Margarethe, et al.. (1990). Binding of protein C inhibitor (PCI) to transformed human epithelial kidney (TCL-598): possible role of cellular proteoglycans. Fibrinolysis and Proteolysis. 4. 28–28. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Selim İşbir Breakdown of academic impact, for papers by H. Lackner Breakdown of academic impact, for papers by Giovanni Melandri Breakdown of academic impact, for papers by Mojca Božič Mijovski Breakdown of academic impact, for papers by H. Köstering Breakdown of academic impact, for papers by Yílmaz Nişancí Breakdown of academic impact, for papers by H. G. Lasch Breakdown of academic impact, for papers by J. Fareed Breakdown of academic impact, for papers by Erik Stoffersen Breakdown of academic impact, for papers by Aria P. Yazdanbakhsh
Rankless by CCL
2026